Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Feucht

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markersJosef Leibold, Judith Feucht, Ameli Halder, et al.
Deutsche Medizinische Wochenschrift (1946)|June 30, 2012
[42-year-old patient with portal hypertension - case 6/2012]Josef Leibold, Serkan Karakaya, Birgit Federmann, et al.
Cancers|July 27, 2024
The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor ImmunityNgoc Thien Thu Nguyen, Rasmus Müller, Daria Briukhovetska, et al.
BMC Cancer|November 16, 2019
Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation studySemjon Willier, Karin Melanie Cabanillas Stanchi, Martina von Have, et al.
Immunology|May 3, 2017
Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotypeNatascha Köstlin, Margit Vogelmann, Bärbel Spring, et al.
BMC Cancer|August 29, 2015
Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantationMichaela Döring, Karin Melanie Cabanillas Stanchi, Markus Mezger, et al.
Nature Medicine|January 30, 2019
Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potencyJudith Feucht, Jie Sun, Justin Eyquem, et al.
Annals of Hematology|November 28, 2015
Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patientsMichaela Döring, Karin Melanie Cabanillas Stanchi, Judith Feucht, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2018
Induction of a central memory and stem cell memory phenotype in functionally active CD4<sup>+</sup> and CD8<sup>+</sup> CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19<sup>+</sup> acute lymphoblastic leukemiaFranziska Blaeschke, Dana Stenger, Theresa Kaeuferle, et al.
Nature Medicine|December 19, 2018
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potencyJudith Feucht, Jie Sun, Justin Eyquem, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markersJosef Leibold, Judith Feucht, Ameli Halder, et al.
Deutsche Medizinische Wochenschrift (1946)|June 30, 2012
[42-year-old patient with portal hypertension - case 6/2012]Josef Leibold, Serkan Karakaya, Birgit Federmann, et al.
Cancers|July 27, 2024
The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor ImmunityNgoc Thien Thu Nguyen, Rasmus Müller, Daria Briukhovetska, et al.
BMC Cancer|November 16, 2019
Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation studySemjon Willier, Karin Melanie Cabanillas Stanchi, Martina von Have, et al.
Immunology|May 3, 2017
Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotypeNatascha Köstlin, Margit Vogelmann, Bärbel Spring, et al.
BMC Cancer|August 29, 2015
Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantationMichaela Döring, Karin Melanie Cabanillas Stanchi, Markus Mezger, et al.
Nature Medicine|January 30, 2019
Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potencyJudith Feucht, Jie Sun, Justin Eyquem, et al.
Annals of Hematology|November 28, 2015
Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patientsMichaela Döring, Karin Melanie Cabanillas Stanchi, Judith Feucht, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2018
Induction of a central memory and stem cell memory phenotype in functionally active CD4<sup>+</sup> and CD8<sup>+</sup> CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19<sup>+</sup> acute lymphoblastic leukemiaFranziska Blaeschke, Dana Stenger, Theresa Kaeuferle, et al.
Nature Medicine|December 19, 2018
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potencyJudith Feucht, Jie Sun, Justin Eyquem, et al.
Pageof 4